• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Chip for interventional imaging enters market

Article

Other headlinesiCAD hosts webinars on prostate cancer

Chip for interventional imaging enters market
Chip technology that promises to extend the product lifecycle, while reducing the size and energy consumption of interventional radiology equipment is now on the market. The chip, a field-programmable gate array (FPGA), incorporates ContextVision’s GOPView iRVPlus. This software is designed specifically to process fluoroscopy images, such as those accompanying angioplasty or stent replacement, during which real-time images are used to guide catheters. It was unveiled at RSNA 2008.

iCAD hosts webinars on prostate cancer
Computer-aided detection specialist iCAD is reaching out to a broad array of specialists involved in the diagnosis and treatment of prostate cancer, in an effort to highlight advanced image analysis and workflow solutions developed by the company. Two webinars, entitled “Prostate MRI – A Paradigm Shift in Prostate Cancer Diagnosis and Management” and scheduled for Oct. 15 and Nov. 10, will focus on how MR combines with iCAD’s quantitative image analysis software VividLook to support improved prostate cancer management. The company hopes to interest radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians in the course, which will include clinical case reviews. These reviews will demonstrate prostate cancer detection in patients with previously negative prostate biopsy and rising PSA values, as well as the use of dynamic contrast enhanced MR and CAD to monitor prostate cancer response to radiation therapy.

Related Videos
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Related Content
© 2024 MJH Life Sciences

All rights reserved.